|
Volume 271,
Number 3,
Issue of January 19, 1996 pp. 1605-1612
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Proteinase
Inhibitor 6 Cannot Be Secreted, Which Suggests It Is a New Type of
Cellular Serpin
(Received for publication, September 29, 1995)
Fiona L.
Scott,
Paul
B.
Coughlin ,
Catherina
Bird ,
Loretta
Cerruti,
John A.
Hayman
,
Phillip
Bird
We have recently described a new serine proteinase inhibitor,
proteinase inhibitor 6 (PI-6). This serpin has features that suggest it
may function intracellularly, but its close resemblance to ovalbumin
serpins like plasminogen activator inhibitor 2 (PAI-2) raises the
possibility that it is secreted to regulate an extracellular
proteinase. To determine whether PI-6 is secreted, we have examined its
cellular distribution by immunohistochemistry and have attempted to
induce its release from platelets and from cultured cells. We find that
PI-6 is present in endothelial and epithelial cells, but it is
apparently cytoplasmic and it is not released from cells in response to
phorbol ester, dibutyryl cAMP or tumor necrosis factor treatment.
It is also not released from activated platelets. The addition of a
conventional signal peptide to the amino terminus of PI-6 directed its
translocation into the endoplasmic reticulum (ER), resulting in
glycosylation but not secretion of the molecule. By contrast, the
addition of the same signal peptide to PAI-2 markedly enhanced its
translocation and secretion. Glycosylated PI-6 was sequestered in the
ER and was incapable of interacting with thrombin. The failure of PI-6
to move along the secretory pathway, and the loss of inhibitory
function of ER-localized PI-6, demonstrates that unlike PAI-2, PI-6 is
not naturally secreted. Taken together, these results suggest that PI-6
has evolved to fulfil an intracellular role and that it represents a
new type of cellular serpin.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Bots and J. P. Medema
Serpins in T cell immunity
J. Leukoc. Biol.,
November 1, 2008;
84(5):
1238 - 1247.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. L. Scott, J. Sun, J. C. Whisstock, K. Kato, and P. I. Bird
SerpinB6 is an Inhibitor of Kallikrein-8 in Keratinocytes
J. Biochem.,
October 1, 2007;
142(4):
435 - 442.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. L. Scarff, K. S. Ung, H. Nandurkar, P. J. Crack, C. H. Bird, and P. I. Bird
Targeted Disruption of SPI3/Serpinb6 Does Not Result in Developmental or Growth Defects, Leukocyte Dysfunction, or Susceptibility to Stroke
Mol. Cell. Biol.,
May 1, 2004;
24(9):
4075 - 4082.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. M. Strik, A. Wolbink, D. Wouters, B. A. Bladergroen, A. R. Verlaan, I. S. van Houdt, S. Hijlkema, C. E. Hack, and J. A. Kummer
Intracellular serpin SERPINB6 (PI6) is abundantly expressed by human mast cells and forms complexes with {beta}-tryptase monomers
Blood,
April 1, 2004;
103(7):
2710 - 2717.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Hirst, M. S. Buzza, C. H. Bird, H. S. Warren, P. U. Cameron, M. Zhang, P. G. Ashton-Rickardt, and P. I. Bird
The Intracellular Granzyme B Inhibitor, Proteinase Inhibitor 9, Is Up-Regulated During Accessory Cell Maturation and Effector Cell Degranulation, and Its Overexpression Enhances CTL Potency
J. Immunol.,
January 15, 2003;
170(2):
805 - 815.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Benarafa, J. Cooley, W. Zeng, P. I. Bird, and E. Remold-O'Donnell
Characterization of Four Murine Homologs of the Human ov-serpin Monocyte Neutrophil Elastase Inhibitor MNEI (SERPINB1)
J. Biol. Chem.,
October 25, 2002;
277(44):
42028 - 42033.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. H. Bird, E. J. Blink, C. E. Hirst, M. S. Buzza, P. M. Steele, J. Sun, D. A. Jans, and P. I. Bird
Nucleocytoplasmic Distribution of the Ovalbumin Serpin PI-9 Requires a Nonconventional Nuclear Import Pathway and the Export Factor Crm1
Mol. Cell. Biol.,
August 15, 2001;
21(16):
5396 - 5407.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Bladergroen, M. C. M. Strik, N. Bovenschen, O. van Berkum, G. L. Scheffer, C. J. L. M. Meijer, C. E. Hack, and J. A. Kummer
The Granzyme B Inhibitor, Protease Inhibitor 9, Is Mainly Expressed by Dendritic Cells and at Immune-Privileged Sites
J. Immunol.,
March 1, 2001;
166(5):
3218 - 3225.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Mikolajczyk, L. S. Millar, K. M. Marker, H. G. Rittenhouse, R. L. Wolfert, L. S. Marks, M. C. Charlesworth, and D. J. Tindall
Identification of a Novel Complex between Human Kallikrein 2 and Protease Inhibitor-6 in Prostate Cancer Tissue
Cancer Res.,
August 1, 1999;
59(16):
3927 - 3930.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. L. Scott, C. E. Hirst, J. Sun, C. H. Bird, S. P. Bottomley, and P. I. Bird
The Intracellular Serpin Proteinase Inhibitor 6 Is Expressed in Monocytes and Granulocytes and Is a Potent Inhibitor of the Azurophilic Granule Protease, Cathepsin G
Blood,
March 15, 1999;
93(6):
2089 - 2097.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. Antalis, M. La Linn, K. Donnan, L. Mateo, J. Gardner, J. L. Dickinson, K. Buttigieg, and A. Suhrbier
The Serine Proteinase Inhibitor (Serpin) Plasminogen Activation Inhibitor Type 2 Protects against Viral Cytopathic Effects by Constitutive Interferon alpha /beta Priming
J. Exp. Med.,
June 1, 1998;
187(11):
1799 - 1811.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Riewald, T. Chuang, A. Neubauer, H. Riess, and R. R. Schleef
Expression of Bomapin, a Novel Human Serpin, in Normal/Malignant Hematopoiesis and in the Monocytic Cell Lines THP-1 and AML-193
Blood,
February 15, 1998;
91(4):
1256 - 1262.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Schwartz
Cell Death and the Caspase Cascade
Circulation,
January 27, 1998;
97(3):
227 - 229.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Dahlen, F. Jean, G. Thomas, D. C. Foster, and W. Kisiel
Inhibition of Soluble Recombinant Furin by Human Proteinase Inhibitor 8
J. Biol. Chem.,
January 23, 1998;
273(4):
1851 - 1854.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Sun, C. H. Bird, V. Sutton, L. McDonald, P. B. Coughlin, T. A. De Jong, J. A. Trapani, and P. I. Bird
A Cytosolic Granzyme B Inhibitor Related to the Viral Apoptotic Regulator Cytokine Response Modifier A Is Present in Cytotoxic Lymphocytes
J. Biol. Chem.,
November 1, 1996;
271(44):
27802 - 27809.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Riewald and R. R. Schleef
Human Cytoplasmic Antiproteinase Neutralizes Rapidly and Efficiently Chymotrypsin and Trypsin-like Proteases Utilizing Distinct Reactive Site Residues
J. Biol. Chem.,
June 14, 1996;
271(24):
14526 - 14532.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kato, T. Kishi, T. Kamachi, M. Akisada, T. Oka, R. Midorikawa, K. Takio, N. Dohmae, P. I. Bird, J. Sun, et al.
Serine Proteinase Inhibitor 3 and Murinoglobulin I Are Potent Inhibitors of Neuropsin in Adult Mouse Brain
J. Biol. Chem.,
April 27, 2001;
276(18):
14562 - 14571.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|